INR 6090.0
(-0.54%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 190 Million INR | -19.49% |
2022 | 236 Million INR | -4.07% |
2021 | 246 Million INR | 8.85% |
2020 | 226 Million INR | 0.0% |
2019 | - INR | 0.0% |
2018 | - INR | 0.0% |
2017 | - INR | 0.0% |
2016 | - INR | -100.0% |
2015 | 15 Million INR | 0.0% |
2014 | - INR | 0.0% |
2013 | - INR | 0.0% |
2012 | - INR | 0.0% |
2011 | - INR | 0.0% |
2010 | - INR | 0.0% |
2009 | - INR | 0.0% |
2008 | - INR | 0.0% |
2007 | - INR | 0.0% |
2006 | - INR | 0.0% |
2005 | - INR | 0.0% |
2004 | - INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 221 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 190 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 190 Million INR | -19.49% |
2023 Q2 | 195 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 225 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 FY | 236 Million INR | -4.07% |
2022 Q4 | 236 Million INR | 0.0% |
2021 Q4 | 246 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 246 Million INR | 8.85% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 268 Million INR | 0.0% |
2020 Q4 | 226 Million INR | 0.0% |
2020 FY | 226 Million INR | 0.0% |
2020 Q2 | 239 Million INR | 0.0% |
2019 FY | - INR | 0.0% |
2019 Q4 | - INR | 0.0% |
2019 Q2 | - INR | 0.0% |
2018 Q4 | - INR | 0.0% |
2018 Q2 | - INR | 0.0% |
2018 FY | - INR | 0.0% |
2017 FY | - INR | 0.0% |
2017 Q2 | - INR | 0.0% |
2017 Q4 | - INR | 0.0% |
2016 Q4 | - INR | 0.0% |
2016 FY | - INR | -100.0% |
2016 Q2 | - INR | 0.0% |
2015 Q2 | - INR | 0.0% |
2015 FY | 15 Million INR | 0.0% |
2015 Q4 | - INR | 0.0% |
2014 Q4 | - INR | 0.0% |
2014 Q2 | - INR | 0.0% |
2014 FY | - INR | 0.0% |
2013 Q2 | - INR | 0.0% |
2013 FY | - INR | 0.0% |
2013 Q4 | - INR | 0.0% |
2012 Q4 | - INR | 0.0% |
2012 FY | - INR | 0.0% |
2012 Q2 | - INR | 0.0% |
2011 FY | - INR | 0.0% |
2011 Q4 | - INR | 0.0% |
2010 FY | - INR | 0.0% |
2009 FY | - INR | 0.0% |
2008 FY | - INR | 0.0% |
2007 FY | - INR | 0.0% |
2006 FY | - INR | 0.0% |
2005 FY | - INR | 0.0% |
2004 FY | - INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott India Limited | 832.3 Million INR | 77.172% |
Cipla Limited | 5.59 Billion INR | 96.604% |
Gland Pharma Limited | 3.72 Billion INR | 94.895% |
GlaxoSmithKline Pharmaceuticals Limited | 186.65 Million INR | -1.795% |
Kopran Limited | 992.28 Million INR | 80.852% |
Marksans Pharma Limited | 2.44 Billion INR | 92.215% |
NGL Fine-Chem Limited | 324.42 Million INR | 41.435% |
Pfizer Limited | 945.4 Million INR | 79.903% |
SMS Pharmaceuticals Limited | 2.8 Billion INR | 93.233% |